NCT06945718
Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Extended Lymphadenectomy Beyond D2 for Locally Advanced Gastric Cancer (FUGES-30)
At risk: Primary completion moved at least 8 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Apr 1, 2027 to Dec 31, 2027 Show 5 more changesShow less
- Enrollment increased: 760 → 1150 participants
- Eligibility criteria revised
- Study completion pushed from May 1, 2030 to Dec 31, 2030
- Start date changed from estimate of May 1, 2025 to Dec 31, 2024
- Secondary endpoints: details revised at 2 of 21 entries
- Notable Phase: Not applicable to Not specified
- Eligibility criteria shortened, about 7 words
- Site contact updated
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
3-year disease free survival rate
Timeframe: 3 years
Secondary (21)
Total number of retrieved lymph nodes
Noncompliance rate of lymph node dissection
Relationship between fluorescent lymph nodes in group A and total number of lymph nodes in group A
Relationship between fluorescent lymph nodes in Group A and positive lymph nodes in Group A (positive rate)
Relationship between fluorescent lymph nodes in Group A and negative lymph nodes in Group A (false positive rate)
Show 16 moreShow less
Relationship between non-fluorescent lymph nodes in Group A and negative lymph nodes in group A (negative rate)
Relationship between nonfluorescent lymph nodes in Group A and positive lymph nodes in Group A (false negative rate)
Relationship between fluorescent lymph nodes in group B and total number of lymph nodes in group B
Relationship between fluorescent lymph nodes in Group B and positive lymph nodes in Group B (positive rate)
Relationship between fluorescent lymph nodes in Group B and negative lymph nodes in Group B (false positive rate)
Relationship between non-fluorescent lymph nodes in Group B and negative lymph nodes in group B (negative rate)
Relationship between nonfluorescent lymph nodes in Group B and positive lymph nodes in Group B (false negative rate)
Number of metastatic lymph nodes
Metastasis rate of lymph nodes
Postoperative complications
Mortality rates
3-year overall survival rate
3-year recurrence pattern
Postoperative recovery course
The incidence of intraoperative complications
Inflammatory and immune response
Arms and interventions
laparoscopic gastrectomy with beyond D2 regional fluorescent lymph node dissection with ICG group
ICG with D2+ group
laparoscopic gastrectomy with D2 regional lymph node dissection with ICG group
ICG with D2 group
Procedures: beyond D2 regional lymph node dissection
Sites
1 site in 1 country
- Fujian Medical University Union HospitalFuzhou, Fujian, China